RWS Holdings plc Stock London S.E.
Equities
GB0033673939
Business Support Services
End-of-day quote
Other stock markets
|
||
- GBX | - |
05-07 | AstraZeneca target raised; Antofagasta lowered | AN |
05-02 | Deutsche Bank likes TP ICAP but says sell CMC | AN |
Sales 2024 * | 739M 925M 1.26B | Sales 2025 * | 768M 961M 1.31B | Capitalization | 656M 822M 1.12B |
---|---|---|---|---|---|
Net income 2024 * | 43M 53.84M 73.61M | Net income 2025 * | 55M 68.87M 94.15M | EV / Sales 2024 * | 0.88 x |
Net cash position 2024 * | 7.13M 8.93M 12.21M | Net cash position 2025 * | 43.1M 53.97M 73.78M | EV / Sales 2025 * | 0.8 x |
P/E ratio 2024 * |
14.9
x | P/E ratio 2025 * |
11.3
x | Employees | - |
Yield 2024 * |
6.98% | Yield 2025 * |
7.56% | Free-Float | 75.14% |
Latest transcript on RWS Holdings plc
Managers | Title | Age | Since |
---|---|---|---|
Ian El-Mokadem
CEO | Chief Executive Officer | 56 | 21-07-18 |
Candida Davies
DFI | Director of Finance/CFO | 50 | 22-10-02 |
Jim McHugh
HRO | Human Resources Officer | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gordon Stuart
BRD | Director/Board Member | 61 | 20-11-03 |
David Clayton
BRD | Director/Board Member | 67 | 20-11-03 |
Andrew Brode
BRD | Director/Board Member | 84 | 00-04-10 |
1st Jan change | Capi. | |
---|---|---|
+16.20% | 71.05B | |
+7.27% | 17.43B | |
+14.34% | 13.99B | |
+23.04% | 13.75B | |
+17.76% | 10.09B | |
-22.30% | 6.71B | |
-4.35% | 5.98B | |
+1.07% | 5.15B | |
-0.71% | 4.98B |